Bluejay Diagnostics, Inc. Increase (Decrease) in Accounts Payable, Trade
Bluejay Diagnostics, Inc. (BJDX) reported Increase (Decrease) in Accounts Payable, Trade of -$81.07 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2022-11-09
- Bluejay Diagnostics, Inc. increase (decrease) in accounts payable, trade for the quarter ending 2022-09-30 was $18.60K, a 39.12% increase year-over-year.
- Bluejay Diagnostics, Inc. increase (decrease) in accounts payable, trade for the quarter ending 2022-06-30 was -$520.73K, a 789.36% decline year-over-year.
- Bluejay Diagnostics, Inc. increase (decrease) in accounts payable, trade for the quarter ending 2022-03-31 was $421.06K.
- Bluejay Diagnostics, Inc. increase (decrease) in accounts payable, trade for the quarter ending 2021-12-31 was $5.87K, a 95.62% decline year-over-year.
- Bluejay Diagnostics, Inc. increase (decrease) in accounts payable, trade for fiscal 2021 was -$79.15K, a 122.89% decline from fiscal 2020.
- Bluejay Diagnostics, Inc. increase (decrease) in accounts payable, trade for fiscal 2020 was $345.80K.
| Period end | Increase (Decrease) in Accounts Payable, Trade 3 month | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 9 month | Increase (Decrease) in Accounts Payable, Trade 12 month |
|---|---|---|---|---|
| 2022-09-30 | $18.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$502.13K derived: sum of 2 quarters · filed 2022-11-09 | -$81.07K 10-Q · filed 2022-11-09 | -$75.20K derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | -$520.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$99.67K 10-Q · filed 2022-08-10 | -$93.80K derived: sum of 3 quarters · filed 2022-08-10 | -$80.43K derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-03-31 | $421.06K 10-Q · filed 2022-05-09 | $426.92K derived: sum of 2 quarters · filed 2022-05-09 | $440.30K derived: sum of 3 quarters · filed 2022-11-09 | $515.83K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-12-31 | $5.87K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $19.24K derived: sum of 2 quarters · filed 2022-11-09 | $94.78K derived: sum of 3 quarters · filed 2022-11-09 | -$79.15K 10-K · filed 2022-03-10 |
| 2021-09-30 | $13.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $88.91K derived: sum of 2 quarters · filed 2022-11-09 | -$85.02K 10-Q · filed 2022-11-09 | $48.79K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $75.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$98.39K 10-Q · filed 2022-08-10 | $35.42K derived: sum of 3 quarters · filed 2022-08-10 | |
| 2021-03-31 | -$173.93K 10-Q · filed 2022-05-09 | -$40.12K derived: sum of 2 quarters · filed 2022-05-09 | ||
| 2020-12-31 | $133.81K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $345.80K 10-K · filed 2022-03-10 | ||
| 2020-09-30 | $212.00K 10-Q · filed 2021-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |